English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 121 | Tables: 122 | Medical Devices & Consumables
The global Inhalation and Nasal Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhalation and Nasal Drug Delivery Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhalation and nasal drug delivery devices are pharmaceutical technologies designed to administer medications directly to the respiratory system through inhalation or nasal routes. These devices include inhalers, nebulizers, nasal sprays, and nasal inhalers, each tailored to deliver specific types of medications such as bronchodilators, corticosteroids, antihistamines, or decongestants. Inhalation devices are commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, delivering drugs directly to the lungs for rapid absorption and localized therapeutic effects. Nasal drug delivery devices, on the other hand, are used to administer medications to the nasal mucosa for the treatment of allergies, sinusitis, nasal congestion, or systemic conditions. These devices offer advantages such as targeted drug delivery, fast onset of action, reduced systemic side effects, and improved patient compliance, making them valuable tools in the management of respiratory and nasal diseases.
The North American market for Inhalation and Nasal Drug Delivery Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Inhalation and Nasal Drug Delivery Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Inhalation and Nasal Drug Delivery Devices include GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Viatris, Merck, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Inhalation and Nasal Drug Delivery Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inhalation and Nasal Drug Delivery Devices. The Inhalation and Nasal Drug Delivery Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Inhalation and Nasal Drug Delivery Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Inhalation and Nasal Drug Delivery Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GlaxoSmithKline (GSK)
AstraZeneca
Boehringer Ingelheim
Viatris
Merck
Novartis
AptarGroup
Chiesi Farmaceutici
Koninklijke Philips
Teva Pharmaceutical Industries
Monaghan Medical
OMRON
PARI International
Vectura
H&T Presspart
Segment by Type
Metered- dose Inhalers
Dry-powder Inhalers
Nebulizers
by Application
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Cystic Fibrosis (CF)
Idiopathic Pulmonary Fibrosis (IPF)
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Inhalation and Nasal Drug Delivery Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Inhalation and Nasal Drug Delivery Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Inhalation and Nasal Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Inhalation and Nasal Drug Delivery Devices by Type
1.2.1 Global Inhalation and Nasal Drug Delivery Devices Market Value by Type: 2025 vs 2032
1.2.2 Metered- dose Inhalers
1.2.3 Dry-powder Inhalers
1.2.4 Nebulizers
1.3 Inhalation and Nasal Drug Delivery Devices by Application
1.3.1 Global Inhalation and Nasal Drug Delivery Devices Market Value by Application: 2025 vs 2032
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
1.3.4 Cystic Fibrosis (CF)
1.3.5 Idiopathic Pulmonary Fibrosis (IPF)
1.3.6 Others
1.4 Global Inhalation and Nasal Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Inhalation and Nasal Drug Delivery Devices Revenue 2021–2032
1.4.2 Global Inhalation and Nasal Drug Delivery Devices Sales 2021–2032
1.4.3 Global Inhalation and Nasal Drug Delivery Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Inhalation and Nasal Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Inhalation and Nasal Drug Delivery Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Inhalation and Nasal Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Product Types and Applications
2.7 Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Date of Entry into the Industry
2.8 Global Inhalation and Nasal Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Inhalation and Nasal Drug Delivery Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Inhalation and Nasal Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Inhalation and Nasal Drug Delivery Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalation and Nasal Drug Delivery Devices Market Scenario by Region
3.1 Global Inhalation and Nasal Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Inhalation and Nasal Drug Delivery Devices Sales by Region: 2021–2032
3.2.1 Global Inhalation and Nasal Drug Delivery Devices Sales by Region: 2021–2026
3.2.2 Global Inhalation and Nasal Drug Delivery Devices Sales by Region: 2027–2032
3.3 Global Inhalation and Nasal Drug Delivery Devices Revenue by Region: 2021–2032
3.3.1 Global Inhalation and Nasal Drug Delivery Devices Revenue by Region: 2021–2026
3.3.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Region: 2027–2032
3.4 North America Inhalation and Nasal Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Inhalation and Nasal Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Inhalation and Nasal Drug Delivery Devices Sales by Country (2021–2032)
3.4.3 North America Inhalation and Nasal Drug Delivery Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation and Nasal Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Inhalation and Nasal Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Inhalation and Nasal Drug Delivery Devices Sales by Country (2021–2032)
3.5.3 Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation and Nasal Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalation and Nasal Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Inhalation and Nasal Drug Delivery Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Inhalation and Nasal Drug Delivery Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhalation and Nasal Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Inhalation and Nasal Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Inhalation and Nasal Drug Delivery Devices Sales by Country (2021–2032)
3.7.3 Latin America Inhalation and Nasal Drug Delivery Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhalation and Nasal Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation and Nasal Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Inhalation and Nasal Drug Delivery Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Inhalation and Nasal Drug Delivery Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation and Nasal Drug Delivery Devices Sales by Type (2021–2032)
4.1.1 Global Inhalation and Nasal Drug Delivery Devices Sales by Type (2021–2026)
4.1.2 Global Inhalation and Nasal Drug Delivery Devices Sales by Type (2027–2032)
4.1.3 Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2021–2032)
4.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Type (2021–2032)
4.2.1 Global Inhalation and Nasal Drug Delivery Devices Revenue by Type (2021–2026)
4.2.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Type (2027–2032)
4.2.3 Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Type (2021–2032)
4.3 Global Inhalation and Nasal Drug Delivery Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Inhalation and Nasal Drug Delivery Devices Sales by Application (2021–2032)
5.1.1 Global Inhalation and Nasal Drug Delivery Devices Sales by Application (2021–2026)
5.1.2 Global Inhalation and Nasal Drug Delivery Devices Sales by Application (2027–2032)
5.1.3 Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2021–2032)
5.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Application (2021–2032)
5.2.1 Global Inhalation and Nasal Drug Delivery Devices Revenue by Application (2021–2026)
5.2.2 Global Inhalation and Nasal Drug Delivery Devices Revenue by Application (2027–2032)
5.2.3 Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Application (2021–2032)
5.3 Global Inhalation and Nasal Drug Delivery Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline (GSK)
6.1.1 GlaxoSmithKline (GSK) Company Information
6.1.2 GlaxoSmithKline (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Viatris Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Merck Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Novartis Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AptarGroup
6.7.1 AptarGroup Company Information
6.7.2 AptarGroup Description and Business Overview
6.7.3 AptarGroup Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AptarGroup Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.7.5 AptarGroup Recent Developments/Updates
6.8 Chiesi Farmaceutici
6.8.1 Chiesi Farmaceutici Company Information
6.8.2 Chiesi Farmaceutici Description and Business Overview
6.8.3 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.8.5 Chiesi Farmaceutici Recent Developments/Updates
6.9 Koninklijke Philips
6.9.1 Koninklijke Philips Company Information
6.9.2 Koninklijke Philips Description and Business Overview
6.9.3 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.9.5 Koninklijke Philips Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Monaghan Medical
6.11.1 Monaghan Medical Company Information
6.11.2 Monaghan Medical Description and Business Overview
6.11.3 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Monaghan Medical Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.11.5 Monaghan Medical Recent Developments/Updates
6.12 OMRON
6.12.1 OMRON Company Information
6.12.2 OMRON Description and Business Overview
6.12.3 OMRON Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 OMRON Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.12.5 OMRON Recent Developments/Updates
6.13 PARI International
6.13.1 PARI International Company Information
6.13.2 PARI International Description and Business Overview
6.13.3 PARI International Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 PARI International Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.13.5 PARI International Recent Developments/Updates
6.14 Vectura
6.14.1 Vectura Company Information
6.14.2 Vectura Description and Business Overview
6.14.3 Vectura Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Vectura Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.14.5 Vectura Recent Developments/Updates
6.15 H&T Presspart
6.15.1 H&T Presspart Company Information
6.15.2 H&T Presspart Description and Business Overview
6.15.3 H&T Presspart Inhalation and Nasal Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 H&T Presspart Inhalation and Nasal Drug Delivery Devices Product Portfolio
6.15.5 H&T Presspart Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation and Nasal Drug Delivery Devices Industry Chain Analysis
7.2 Inhalation and Nasal Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation and Nasal Drug Delivery Devices Production Mode & Process Analysis
7.4 Inhalation and Nasal Drug Delivery Devices Sales and Marketing
7.4.1 Inhalation and Nasal Drug Delivery Devices Sales Channels
7.4.2 Inhalation and Nasal Drug Delivery Devices Distributors
7.5 Inhalation and Nasal Drug Delivery Devices Customer Analysis
8 Inhalation and Nasal Drug Delivery Devices Market Dynamics
8.1 Inhalation and Nasal Drug Delivery Devices Industry Trends
8.2 Inhalation and Nasal Drug Delivery Devices Market Drivers
8.3 Inhalation and Nasal Drug Delivery Devices Market Challenges
8.4 Inhalation and Nasal Drug Delivery Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Inhalation and Nasal Drug Delivery Devices Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Inhalation and Nasal Drug Delivery Devices Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Inhalation and Nasal Drug Delivery Devices Market Competitive Situation by Manufacturers in 2025
Table 4. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Inhalation and Nasal Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Inhalation and Nasal Drug Delivery Devices Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Inhalation and Nasal Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Inhalation and Nasal Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Product Types and Applications
Table 12. Global Key Manufacturers of Inhalation and Nasal Drug Delivery Devices, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhalation and Nasal Drug Delivery Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhalation and Nasal Drug Delivery Devices Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhalation and Nasal Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Inhalation and Nasal Drug Delivery Devices Sales by Region (K Units), 2021–2026
Table 18. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Region (2021–2026)
Table 19. Global Inhalation and Nasal Drug Delivery Devices Sales by Region (K Units), 2027–2032
Table 20. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Region (2027–2032)
Table 21. Global Inhalation and Nasal Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 22. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Region (2021–2026)
Table 23. Global Inhalation and Nasal Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 24. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Region (2027–2032)
Table 25. North America Inhalation and Nasal Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 27. North America Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 28. North America Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 29. North America Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 32. Europe Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 33. Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Inhalation and Nasal Drug Delivery Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Inhalation and Nasal Drug Delivery Devices Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Inhalation and Nasal Drug Delivery Devices Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Inhalation and Nasal Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Inhalation and Nasal Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Inhalation and Nasal Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 42. Latin America Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 43. Latin America Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
Table 50. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units) by Type (2021–2026)
Table 51. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units) by Type (2027–2032)
Table 52. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2021–2026)
Table 53. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Type (2027–2032)
Table 54. Global Inhalation and Nasal Drug Delivery Devices Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Inhalation and Nasal Drug Delivery Devices Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Type (2021–2026)
Table 57. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Type (2027–2032)
Table 58. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Type (2021–2026)
Table 59. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Type (2027–2032)
Table 60. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units) by Application (2021–2026)
Table 61. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units) by Application (2027–2032)
Table 62. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2021–2026)
Table 63. Global Inhalation and Nasal Drug Delivery Devices Sales Market Share by Application (2027–2032)
Table 64. Global Inhalation and Nasal Drug Delivery Devices Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Inhalation and Nasal Drug Delivery Devices Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Application (2021–2026)
Table 67. Global Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Application (2027–2032)
Table 68. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Application (2021–2026)
Table 69. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Application (2027–2032)
Table 70. GlaxoSmithKline (GSK) Company Information
Table 71. GlaxoSmithKline (GSK) Description and Business Overview
Table 72. GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. GlaxoSmithKline (GSK) Inhalation and Nasal Drug Delivery Devices Product
Table 74. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. AstraZeneca Inhalation and Nasal Drug Delivery Devices Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Boehringer Ingelheim Inhalation and Nasal Drug Delivery Devices Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Viatris Company Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Viatris Inhalation and Nasal Drug Delivery Devices Product
Table 89. Viatris Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Merck Inhalation and Nasal Drug Delivery Devices Product
Table 94. Merck Recent Developments/Updates
Table 95. Novartis Company Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Novartis Inhalation and Nasal Drug Delivery Devices Product
Table 99. Novartis Recent Developments/Updates
Table 100. AptarGroup Company Information
Table 101. AptarGroup Description and Business Overview
Table 102. AptarGroup Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AptarGroup Inhalation and Nasal Drug Delivery Devices Product
Table 104. AptarGroup Recent Developments/Updates
Table 105. Chiesi Farmaceutici Company Information
Table 106. Chiesi Farmaceutici Description and Business Overview
Table 107. Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Chiesi Farmaceutici Inhalation and Nasal Drug Delivery Devices Product
Table 109. Chiesi Farmaceutici Recent Developments/Updates
Table 110. Koninklijke Philips Company Information
Table 111. Koninklijke Philips Description and Business Overview
Table 112. Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Koninklijke Philips Inhalation and Nasal Drug Delivery Devices Product
Table 114. Koninklijke Philips Recent Developments/Updates
Table 115. Teva Pharmaceutical Industries Company Information
Table 116. Teva Pharmaceutical Industries Description and Business Overview
Table 117. Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Teva Pharmaceutical Industries Inhalation and Nasal Drug Delivery Devices Product
Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
Table 120. Monaghan Medical Company Information
Table 121. Monaghan Medical Description and Business Overview
Table 122. Monaghan Medical Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Monaghan Medical Inhalation and Nasal Drug Delivery Devices Product
Table 124. Monaghan Medical Recent Developments/Updates
Table 125. OMRON Company Information
Table 126. OMRON Description and Business Overview
Table 127. OMRON Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. OMRON Inhalation and Nasal Drug Delivery Devices Product
Table 129. OMRON Recent Developments/Updates
Table 130. PARI International Company Information
Table 131. PARI International Description and Business Overview
Table 132. PARI International Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. PARI International Inhalation and Nasal Drug Delivery Devices Product
Table 134. PARI International Recent Developments/Updates
Table 135. Vectura Company Information
Table 136. Vectura Description and Business Overview
Table 137. Vectura Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Vectura Inhalation and Nasal Drug Delivery Devices Product
Table 139. Vectura Recent Developments/Updates
Table 140. H&T Presspart Company Information
Table 141. H&T Presspart Description and Business Overview
Table 142. H&T Presspart Inhalation and Nasal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. H&T Presspart Inhalation and Nasal Drug Delivery Devices Product
Table 144. H&T Presspart Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Inhalation and Nasal Drug Delivery Devices Distributors List
Table 148. Inhalation and Nasal Drug Delivery Devices Customers List
Table 149. Inhalation and Nasal Drug Delivery Devices Market Trends
Table 150. Inhalation and Nasal Drug Delivery Devices Market Drivers
Table 151. Inhalation and Nasal Drug Delivery Devices Market Challenges
Table 152. Inhalation and Nasal Drug Delivery Devices Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhalation and Nasal Drug Delivery Devices
Figure 2. Global Inhalation and Nasal Drug Delivery Devices Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Inhalation and Nasal Drug Delivery Devices Market Share by Type: 2025 & 2032
Figure 4. Metered- dose Inhalers Product Picture
Figure 5. Dry-powder Inhalers Product Picture
Figure 6. Nebulizers Product Picture
Figure 7. Global Inhalation and Nasal Drug Delivery Devices Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Inhalation and Nasal Drug Delivery Devices Market Share by Application: 2025 & 2032
Figure 9. Asthma
Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
Figure 11. Cystic Fibrosis (CF)
Figure 12. Idiopathic Pulmonary Fibrosis (IPF)
Figure 13. Others
Figure 14. Global Inhalation and Nasal Drug Delivery Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Inhalation and Nasal Drug Delivery Devices Market Size (US$ Million), 2021–2032
Figure 16. Global Inhalation and Nasal Drug Delivery Devices Sales (K Units), 2021–2032
Figure 17. Global Inhalation and Nasal Drug Delivery Devices Average Price (US$/Unit), 2021–2032
Figure 18. Inhalation and Nasal Drug Delivery Devices Report Years Considered
Figure 19. Inhalation and Nasal Drug Delivery Devices Sales Share by Manufacturers in 2025
Figure 20. Global Inhalation and Nasal Drug Delivery Devices Revenue Share by Manufacturers in 2025
Figure 21. Top 5 and Top 10 Global Inhalation and Nasal Drug Delivery Devices Players: Market Share by Revenue in Inhalation and Nasal Drug Delivery Devices in 2025
Figure 22. Inhalation and Nasal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 23. Global Inhalation and Nasal Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 24. North America Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 25. North America Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 26. United States Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Canada Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Europe Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 29. Europe Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 30. Germany Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. France Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. U.K. Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Italy Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Russia Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Asia Pacific Inhalation and Nasal Drug Delivery Devices Sales Market Share by Region (2021–2032)
Figure 36. Asia Pacific Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Region (2021–2032)
Figure 37. China Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Japan Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. South Korea Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. India Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Australia Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. China Taiwan Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Southeast Asia Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 45. Latin America Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Colombia Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Inhalation and Nasal Drug Delivery Devices Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Inhalation and Nasal Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Inhalation and Nasal Drug Delivery Devices by Type (2021–2032)
Figure 56. Global Revenue Market Share of Inhalation and Nasal Drug Delivery Devices by Type (2021–2032)
Figure 57. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Type (2021–2032)
Figure 58. Global Sales Market Share of Inhalation and Nasal Drug Delivery Devices by Application (2021–2032)
Figure 59. Global Revenue Market Share of Inhalation and Nasal Drug Delivery Devices by Application (2021–2032)
Figure 60. Global Inhalation and Nasal Drug Delivery Devices Price (US$/Unit) by Application (2021–2032)
Figure 61. Inhalation and Nasal Drug Delivery Devices Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
